查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲下一代 IVD 市场：分析与预测（2023-2033）
市场调查报告书
商品编码
1421496

欧洲下一代 IVD 市场：分析与预测（2023-2033）

Europe Next Generation IVD Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 117 Pages | 商品交期: 1-5个工作天内

价格

2023年欧洲下一代IVD市场规模将达242亿美元。

预计2023年至2033年该市场将以5.26%的复合年增长率成长，2033年达到404.1亿美元。利用诊断领域的新技术和创新有能力刺激下一代 IVD（体外诊断）市场的扩张。分子诊断、基因组学和次世代定序(NGS) 预计将成为这一增长的关键驱动力，为增强疾病诊断提供新的机会，进而重塑患者的治疗结果。

主要市场统计数据
预测期 2023-2033
2023年评估价值 242亿美元
2033年预测 404.1亿美元
复合年增长率 5.26%

欧洲的下一代 IVD（体外诊断）市场正在经历显着的成长和转型。该市场包括各种先进的诊断技术和工具，正在彻底改变该地区的医疗保健。推动这一市场的关键因素包括慢性病的流行、个人化医疗需求的增加以及对疾病早期检测和管理的日益重视。分子诊断、基因组学和次世代定序(NGS) 处于技术创新的前沿，使医疗保健专业人员能够准确地了解患者的病情。这些技术提高了诊断各种疾病的准确性、速度和效率，包括癌症、感染疾病和遗传性疾病。

此外，欧洲市场的特点是研发活动活跃，促进了 IVD 解决方案的不断进步。监管支持和严格的品质标准确保这些诊断的安全性和有效性。欧洲下一代 IVD 市场专注于改善患者治疗效果和优化医疗资源，有望持续增长和创新，为改善该地区的整体医疗保健做出贡献。Masu。

该报告考察了欧洲下一代 IVD 市场，并提供了市场概述，包括按类型、最终用户、国家/地区分類的趋势以及进入市场的公司概况。

目录

执行摘要

第一章 市场

  • 市场范围
  • 调查方法

第二章 市场概况

  • 介绍
    • 下一代IVD市场前景
    • 市场规模和成长潜力
    • 下一代体外诊断市场的产品基准（按类型）
  • COVID-19 对下一代 IVD 市场的影响

第三章行业分析

  • 法律要求
    • 欧洲法律要求和框架

第四章市场动态

  • 概述
  • 影响分析
  • 市场驱动力
  • 市场挑战
  • 市场机会

第 5 章 下一代 IVD 市场，按地区，百万美元，2022-2033

  • 概述
  • 欧洲
    • 市场动态
    • 市场规模及预测

第六章 公司简介

  • bioMerieux SA（BioFire Diagnostics）
  • F. Hoffmann-La Roche Ltd.（Roche Molecular Systems, Inc.）
  • QIAGEN NV
  • Siemens Healthineers AG
Product Code: BHP1842S

“The Europe Next-Generation IVD Market Expected to Reach $40.41 Billion by 2033.”

Introduction to Europe Next-Generation IVD (In vitro diagnostics) Market

The Europe next-generation IVD market was valued at $24.20 billion in 2023 and is expected to reach $40.41 billion by 2033, growing at a CAGR of 5.26% between 2023 and 2033. The utilization of emerging technologies and innovations in diagnostics has the capacity to stimulate the expansion of the next-generation IVD (In Vitro Diagnostic) market. Molecular diagnostics, genomics, and Next-Generation Sequencing (NGS) are anticipated to be key drivers of this growth, offering fresh opportunities for enhanced disease diagnosis and, consequently, reshaping patient outcomes.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$24.20 Billion
2033 Forecast$40.41 Billion
CAGR5.26%

Market Introduction

The Europe Next-Generation IVD (In Vitro Diagnostics) Market is witnessing significant growth and transformation. It encompasses a diverse range of advanced diagnostic technologies and tools that are revolutionizing healthcare practices in the region. Key factors driving this market include the increasing prevalence of chronic diseases, rising demand for personalized medicine, and a growing emphasis on early disease detection and management. Molecular diagnostics, genomics, and Next-Generation Sequencing (NGS) are at the forefront of innovation, enabling healthcare professionals to obtain precise insights into patients' conditions. These technologies offer enhanced accuracy, speed, and efficiency in diagnosing various diseases, including cancer, infectious diseases, and genetic disorders.

Moreover, the Europe market is characterized by robust research and development activities, fostering continuous advancements in IVD solutions. Regulatory support and stringent quality standards ensure the safety and efficacy of these diagnostics. With a focus on improving patient outcomes and optimizing healthcare resources, the Europe Next-Generation IVD Market is poised for continued growth and innovation, contributing to the region's overall healthcare excellence.

Market Segmentation:

Segmentation 1: by Type

  • Core Laboratory Diagnostics
  • POC Testing
  • Molecular Diagnostics

Segmentation 2: by End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Academic and Research Institutions
  • Other End Users

Segmentation 3: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The Europe next-generation IVD market has been extensively segmented on the basis of various categories, such as type and end user. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe next-generation IVD market has numerous startups paving their way into manufacturing kits, panels, assays, and instruments and entering the market. Key players in the Europe next-generation IVD market analyzed and profiled in the study involve established players that offer various kinds of disease-specific panels and multiplex instruments.

Table of Contents

Executive Summary

1. Markets

  • 1.1. Market Scope
    • 1.1.1. Key Questions Answered in the Report
  • 1.2. Research Methodology
    • 1.2.1. Next-Generation IVD Market: Research Methodology
    • 1.2.2. Data Sources
      • 1.2.2.1. Primary Data Sources
      • 1.2.2.2. Secondary Data Sources
    • 1.2.3. Market Estimation Model
    • 1.2.4. Criteria for Company Profiling

2. Market Overview

  • 2.1. Introduction
    • 2.1.1. Next-Generation IVD Market Outlook
      • 2.1.1.1. POC-IVD
      • 2.1.1.2. Diagnostic Expenditures
      • 2.1.1.3. Pricing Patterns of Next-Generation IVD
    • 2.1.2. Market Size and Growth Potential
      • 2.1.2.1. Short-Term Impact (2020-2025)
      • 2.1.2.2. Long-Term Impact (2026-2033)
    • 2.1.3. Product Benchmarking by Next- Generation In-vitro Diagnostics Market, (by Type)
  • 2.2. COVID-19 Impact on the Next-Generation IVD Market
    • 2.2.1. Impact on Operations
    • 2.2.2. COVID-19 Impact: Current Scenario of the Market
    • 2.2.3. Pre-COVID Assessment
    • 2.2.4. Post-COVID-19 Market Assessment

3. Industry Analysis

  • 3.1. Legal Requirements
    • 3.1.1. Legal Requirements and Framework in Europe

4. Market Dynamics

  • 4.1. Overview
  • 4.2. Impact Analysis
  • 4.3. Market Drivers
    • 4.3.1. Technological Advancements in Next-Generation In-Vitro Diagnostics Transforming Healthcare System
    • 4.3.2. Rising Demand of POC Testing Boosting Next-Generation IVD Market
    • 4.3.3. Growing Incidence of Chronic and Acute Diseases Demanding for Early Treatment
    • 4.3.4. Boost in the Next-Generation IVD Market during COVID-19 Pandemic
  • 4.4. Market Challenges
    • 4.4.1. Regulatory Hurdles Related to Next-Generation IVD Technologies
    • 4.4.2. Poor Reimbursement Scenario
  • 4.5. Market Opportunities
    • 4.5.1. Rising Number of Next-Generation IVD Companies Involved in Business Expansion
    • 4.5.2. Inclination of Emerging Companies toward Next-Generation IVD

5. Next-Generation IVD Market, by Region, $Million, 2022-2033

  • 5.1. Overview
  • 5.2. Europe
    • 5.2.1. Market Dynamics
    • 5.2.2. Market Size and Forecast
      • 5.2.2.1. Europe Next-Generation IVD Market (by End User)
      • 5.2.2.2. Europe Next-Generation IVD Market (by Type)
        • 5.2.2.2.1. Europe Next-Generation Core Laboratory IVD Market, (by Type)
      • 5.2.2.3. Europe Next-Generation IVD Market (by Country)
        • 5.2.2.3.1. Germany
          • 5.2.2.3.1.1. Market Size and Forecast
          • 5.2.2.3.1.1.1. Germany Next-Generation IVD Market (by End User)
          • 5.2.2.3.1.1.2. Germany Next-Generation IVD Market (by Type)
        • 5.2.2.3.2. France
          • 5.2.2.3.2.1. Market Size and Forecast
          • 5.2.2.3.2.1.1. France Next-Generation IVD Market (by End User)
          • 5.2.2.3.2.1.2. France Next-Generation IVD Market (by Type)
        • 5.2.2.3.3. U.K.
          • 5.2.2.3.3.1. Market Size and Forecast
          • 5.2.2.3.3.1.1. U.K. Next-Generation IVD Market (by End User)
          • 5.2.2.3.3.1.2. U.K. Next-Generation IVD Market (by Type)
        • 5.2.2.3.4. Italy
          • 5.2.2.3.4.1. Market Size and Forecast
          • 5.2.2.3.4.1.1. Italy Next-Generation IVD Market (by End User)
          • 5.2.2.3.4.1.2. Italy Next-Generation IVD Market (by Type)
        • 5.2.2.3.5. Spain
          • 5.2.2.3.5.1. Market Size and Forecast
          • 5.2.2.3.5.1.1. Spain Next-Generation IVD Market (by End User)
          • 5.2.2.3.5.1.2. Spain Next-Generation IVD Market (by Type)
        • 5.2.2.3.6. Rest-of-Europe
          • 5.2.2.3.6.1. Market Size and Forecast
          • 5.2.2.3.6.1.1. Rest-of-Europe Next-Generation IVD Market (by End User)
          • 5.2.2.3.6.1.2. Rest-of-Europe Next-Generation IVD Market (by Type)

6. Company Profiles

  • 6.1. Overview
  • 6.2. bioMerieux SA (BioFire Diagnostics)
    • 6.2.1. Company Overview
    • 6.2.2. Role of bioMerieux SA (BioFire Diagnostics) in the Next-Generation IVD Market
    • 6.2.3. Financials
    • 6.2.4. Recent Developments
      • 6.2.4.1. Corporate Strategies
      • 6.2.4.2. Business Strategies
    • 6.2.5. Analyst Perspective
  • 6.3. F. Hoffmann-La Roche Ltd. (Roche Molecular Systems, Inc.)
    • 6.3.1. Company Overview
    • 6.3.2. Role of F. Hoffmann-La Roche Ltd. in the Next-Generation IVD Market
    • 6.3.3. Financials
    • 6.3.4. Recent Developments
      • 6.3.4.1. Business Strategies
    • 6.3.5. Analyst Perspective
  • 6.4. QIAGEN N.V.
    • 6.4.1. Company Overview
    • 6.4.2. Role of QIAGEN N.V. in the Next-Generation IVD Market
    • 6.4.3. Financials
    • 6.4.4. Recent Developments
      • 6.4.4.1. Corporate Strategies
      • 6.4.4.2. Business Strategies
    • 6.4.5. Analyst Perspective
  • 6.5. Siemens Healthineers AG
    • 6.5.1. Company Overview
    • 6.5.2. Role of Siemens Healthineers AG in the Next-Generation IVD Market
    • 6.5.3. Financials
    • 6.5.4. Recent Developments
      • 6.5.4.1. Corporate Strategies
      • 6.5.4.2. Business Strategies
    • 6.5.5. Analyst Perspective

List of Figures

  • Figure 1: Facts about Europe Next-Generation IVD Market
  • Figure 2: Equipment's used for Next-Generation In-Vitro Diagnostics
  • Figure 3: Europe Next-Generation IVD Market, $Billion, 2022 and 2033
  • Figure 4: Trend Analysis of Next-Generation In-vitro Diagnostics Ecosystem
  • Figure 5: Common Chronic Conditions for Population Above 65 years
  • Figure 6: Key Challenges in the Europe Next-Generation IVD Market based on Primary Respondents
  • Figure 7: New In-Vitro Diagnostics Regulations (IVDR) and Medical Device Regulation (MDR)
  • Figure 8: Major Highlights Witnessed in the Next-Generation IVD Market During COVID-19 Impact
  • Figure 9: Role of POC Diagnostics in Next-Generation IVD Market During Pandemic
  • Figure 10: Leading and Emerging Companies in the Next-Generation IVD Ecosystem
  • Figure 11: Leading Companies in the Next-Generation IVD Ecosystem and Their Market Share (%)
  • Figure 12: Key Developments Undertaken by Companies in the Next-Generation IVD Market, July 2019-June 2023
  • Figure 13: Product Benchmarking of Next-Generation In-Vitro Diagnostics Ecosystem (by Test)
  • Figure 14: Europe Next-Generation IVD Market (by Type), Share (%), 2022 and 2033
  • Figure 15: Europe Next-Generation IVD Market (by End User), Share (%), 2022 and 2033
  • Figure 16: Europe Next-Generation IVD Market, Market Snapshot
  • Figure 17: Next-Generation IVD Market: Research Methodology
  • Figure 18: Primary Research Methodology
  • Figure 19: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 20: Top-Down Approach (Segment-Wise Analysis)
  • Figure 21: Europe Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 22: Product Benchmarking of Next-Generation In-vitro Diagnostics Market (by Type)
  • Figure 23: In-Vitro Diagnostic Trends during the COVID-19 Pandemic
  • Figure 24: Timeline of IVDR 2017/746
  • Figure 25: Next-Generation IVD Market Dynamics
  • Figure 26: Factors Contributing to Growing Demand of POC Testing
  • Figure 27: Current Trend in In-Vitro Diagnostics: From Centralized Laboratory to Point-of-Care Testing
  • Figure 28: Annual Mortality by Chronic Illness in 1990, 2002, and 2020
  • Figure 29: Trend in COVID-19 Diagnostic Test Development and the Used Technology
  • Figure 30: Top Challenges in the IVDR Compliance
  • Figure 31: Key Area of Focus by Next-Generation IVD Companies
  • Figure 32: Next-Generation IVD Market (by Region), Share (%), 2022
  • Figure 33: Next-Generation IVD Market (by Region), $Billion, 2022-2033
  • Figure 34: Europe Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 35: Europe Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 36: Europe Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 37: Europe Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 38: Europe Next-Generation IVD Market (by Country), $Billion, 2022-2033
  • Figure 39: Germany Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 40: Germany Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 41: Germany Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 42: Germany Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 43: France Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 44: France Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 45: France Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 46: France Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 47: U.K. Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 48: U.K. Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 49: U.K. Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 50: U.K. Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 51: Italy Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 52: Italy Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 53: Italy Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 54: Italy Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 55: Spain Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 56: Spain Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 57: Spain Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 58: Spain Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 59: Rest-of-Europe Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 60: Rest-of-Europe Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 61: Rest-of-Europe Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 62: Rest-of-Europe Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 63: Total Number of Companies Profiled
  • Figure 64: bioMerieux SA (BioFire Diagnostics): Product Portfolio
  • Figure 65: bioMerieux SA (BioFire Diagnostics): Overall Financials, $Million, 2020-2022
  • Figure 66: bioMerieux SA (BioFire Diagnostics): Revenue (by Segment), $Million, 2020-2022
  • Figure 67: bioMerieux SA (BioFire Diagnostics): Revenue (by Region), $Million, 2020-2022
  • Figure 68: bioMerieux SA (BioFire Diagnostics): R&D Expenditure, $Million, 2020-2022
  • Figure 69: F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Figure 70: F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2020-2022
  • Figure 71: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2020-2022
  • Figure 72: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2020-2022
  • Figure 73: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2020-2022
  • Figure 74: QIAGEN N.V.: Product Portfolio
  • Figure 75: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
  • Figure 76: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
  • Figure 77: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
  • Figure 78: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
  • Figure 79: Siemens Healthineers AG: Product Portfolio
  • Figure 80: Siemens Healthineers AG: Overall Financials, $Million, 2020-2022
  • Figure 81: Siemens Healthineers AG: Revenue (by Segment), $Million, 2020-2022
  • Figure 82: Siemens Healthineers AG: Revenue (by Region), $Million, 2020-2022
  • Figure 83: Siemens Healthineers AG: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Impact Analysis of Market Drivers, and Restraints on the Europe Next-Generation IVD Market
  • Table 2: Impact of COVID-19 on Different Countries
  • Table 3: Likert Scale
  • Table 4: Impact Analysis of Market Drivers
  • Table 5: Impact Analysis of Market Restraints
  • Table 6: Impact Analysis of Market Opportunities
  • Table 7: Technology Offered by Next-Generation IVD Ecosystem
  • Table 8: Examples of Expansion Strategy by Next-Generation IVD Market Players
  • Table 9: Europe: Market Dynamics